A review of pharmacologic treatments for obsessive-compulsive disorder.
about
What every psychiatrist should know about PANDAS: a reviewInterventions for obsessive compulsive symptoms in people with schizophreniaContemporary assessment and pharmacotherapy of Tourette syndromeSingle photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopramGlutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model.Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and OCD connectionThe role of venlafaxine in the treatment of obsessive-compulsive disorder.Escitalopram in obsessive-compulsive disorder: a case series.Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions.Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.Cognitive behavioral therapy in pharmacoresistant obsessive-compulsive disorder.An update on the pharmacological treatment of obsessive-compulsive disorder.Off-label prescription of quetiapine in psychiatric disorders.Suicidal behaviour of Indian patients with obsessive compulsive disorder.Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive DisorderThe nature, assessment, and treatment of obsessive-compulsive disorder.Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity.An expert opinion on PANDAS/PANS: highlights and controversies.An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.Benefits of CBT for OCD in pregnancyMood in relation to subclinical obsessive-compulsive symptoms.Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.Inappropriate sexual behaviour in a case of ALS and FTD: successful treatment with sertraline.
P2860
Q21203785-BCB32FDE-E1B2-4FB6-A9AD-F5F8EBF8ADC6Q24244391-E5160A50-751E-4D5E-B50C-6D4202D03DF4Q24607941-D591FC9B-CB0E-493D-89AC-1B20298C81B9Q24795008-6018AF6A-0E87-467C-BFF8-BB2CB591C35FQ27340464-1C921724-6C17-4403-8F55-700D3B8BEE22Q35878004-D953674F-CB57-4B04-AC39-6C9DC77D7B1FQ35976946-BFA3B33F-B6EF-4CBA-84BC-8EEC976F838CQ36274266-78D61F9F-DCBC-4336-8917-BBCA963009CDQ36339814-5C615741-AFF4-480C-A24D-1257DC1B990AQ36532129-35D56E5C-44C2-457F-843B-8344A48922B7Q36702575-2B053B66-1777-47BF-8738-4CB4AEB860E3Q36765772-9CC33676-62D9-4AE1-9C0F-4C9D879C28E0Q36870068-109AAB02-965F-40AA-91DF-DB65FB5B0DD3Q36965661-95EEB5FC-F097-4181-84A3-D3631C7B2FB7Q37352930-9FDC5205-5D8A-4919-97BF-8ADA3AE38876Q37982217-7A24FD54-D97F-467C-975A-7E966EB43612Q38157123-3D782226-C2BD-4C52-ABC8-EC67C1FBBFDEQ39302260-31092FDA-1D65-4B51-A452-9516CF409942Q41981820-8B361029-0275-4258-AC6E-792A08B04D74Q42571026-1296256D-A705-4DC7-B881-D4FD11944F6EQ46421232-484DBAE0-0053-4BF6-9317-193C0C9FA620Q46882968-5A40B258-5EDC-4B24-9443-E9DCD55E56F6Q51903015-51508818-25BC-47C7-9090-86583B732B4E
P2860
A review of pharmacologic treatments for obsessive-compulsive disorder.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A review of pharmacologic treatments for obsessive-compulsive disorder.
@ast
A review of pharmacologic treatments for obsessive-compulsive disorder.
@en
type
label
A review of pharmacologic treatments for obsessive-compulsive disorder.
@ast
A review of pharmacologic treatments for obsessive-compulsive disorder.
@en
prefLabel
A review of pharmacologic treatments for obsessive-compulsive disorder.
@ast
A review of pharmacologic treatments for obsessive-compulsive disorder.
@en
P1433
P1476
A review of pharmacologic treatments for obsessive-compulsive disorder.
@en
P2093
Alicia Kaplan
Eric Hollander
P304
P356
10.1176/APPI.PS.54.8.1111
P577
2003-08-01T00:00:00Z